New hope for brain bleed: smarter use of a common drug may prevent worsening
NCT ID NCT07365150
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug tranexamic acid can prevent brain bleed expansion in people with a type of stroke called intracerebral hemorrhage. The researchers are using new criteria to select patients most likely to benefit, based on bleed location and size. About 70 adults will be enrolled within 6 hours of symptoms. The goal is to see if this approach reduces early neurological worsening.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pamela Youde Nethersole Eastern Hospital
NOT_YET_RECRUITINGHong Kong, Hong Kong
-
Prince of Wales Hospital
RECRUITINGHong Kong, Hong Kong
-
The University of Hong Kong
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can blood markers predict brain injury outcomes?
- Can an ancient herbal pill improve outcomes after a bleeding stroke?
- Zapping the vagus nerve: a new hope for Stroke-Weakened arms?
- Ear nerve zaps may aid stroke recovery in kids — a tiny trial puts it to the test
- Could a gentle surgical approach improve outcomes after deep brain bleeding?
- Common ICU procedure may briefly raise brain pressure — study investigates the risk